April 30, 2024 - May 3, 2024

Amkay Products IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Amkay Products IPO.

Amkay Products IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	0	0	0
%	0.00	100.00	0.00	0.00	0.00

Amkay Products IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	May Apply

Amkay Products IPO Review by Dilip Davda (May apply)

[Dilip Davda] The company is in medical device segment, which is not only overcrowded, but also on the verge of saturation point. It’s a highly competitive and fragmented segment post covid. Based on FY24 annualized earnings, the issue is fully priced discounting all near term positives. Well-informed/cash surplus investors may park moderate funds for the medium to long term rewards. Read detail review...

Amkay Products IPO Peer Comparison

Amkay Products Limited peer comparison with similar listed entities. (As on March 31, 2023)

Company Name	EPS (Basic)	EPS (Diluted)	P/E (x)	RoNW (%)
Amkay Products Limited	2.37	2.37		19.57
Hemant Surgical Industries Ltd	10.28	10.28	14.59	32.42
Qms Medical Allied Services Limited	3.90	3.90	26.53	9.06

Notes:

Source -Result/Offer documents of the company for 2023 and stock exchange data dated February 09, 2024. For the Company, they have taken CMP as the issue price of equity shares. Further, the P/E Ratio is based on the CMP of the respective scrips.
The EPS, NAV, RoNW, and revenue from operations of the Company are taken as per the Restated Financial Statement for the Financial Year 2022-23, as adjusted with the effect of the Bonus Issue.
NAV per share is computed as the closing net worth divided by the closing outstanding number of paid-up equity shares as adjusted with the effect of Bonus Issue.
The company's P/E ratio is based on its Annual report/results for the year 2023 and stock exchange data dated February 09, 2024.
RoNW has been computed as net profit after tax divided by closing net worth.

Amkay Products IPO Review by Members

Amkay Products IPO Reviews, analysis and views by popular members. Read Amkay Products Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Amkay Products IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.